`In Reply to Office Action mailed 11/06/2015
`
`Amendments to the Claims:
`
`This listing of claims will replace all prior versions, and listing, of claims in the
`
`application.
`
`Listing of Claims:
`
`1.-14.
`
`(Canceled)
`
`15.
`
`(Currently Amended) An analysis device, comprising:
`
`a microchannel structure rotatable about a rotation axis of the analysis device, the
`
`microchannel structure including apassage a passage and a measuring cell; and
`
`an analysis reagent carried in the passage of the microchannel structure, the analysis
`
`reagent being in a solid and dry state, the analysis reagent comprising a combination of
`
`a polyanionic compound and a bivalent cationic compound, and one substance or one
`
`compound of the substance as an additive,
`
`wherein the substance is at least one selected from the group consisting of:
`
`succinic acid,
`
`gluconic acid,
`
`alanine,
`
`glyeinee
`
`valine,
`
`histidine, w
`
`maltitolranel
`
`mannitel.
`
`16.
`
`(Withdrawn) An analysis device, comprising:
`
`a microchannel structure rotatable about a rotation axis of the analysis device, the
`
`microchannel structure including a passage and a measuring cell;
`
`an analysis reagent carried in the passage of the microchannel structure, the analysis
`
`reagent being in a solid and dry state, the analysis reagent comprising a combination of
`
`a polyanionic compound and a bivalent cationic compound, and one substance or one
`
`compound of the substance as an additive,
`
`
`
`
`
`
`
`
`
`S/N: 14/479,936
`In Reply to Office Action mailed 11/06/2015
`
`wherein the substance is at least one selected from the group consisting of:
`
`dicarboxylic acid,
`
`gluconic acid,
`
`alanine,
`
`glycine,
`
`valine,
`
`histidine,
`
`taurine,
`
`a sugar alcohol,
`
`xylose that is a monosaccharide,
`
`a disaccharide, and
`
`a trisaccharide.
`
`17.
`
`(Currently Amended) The analysis device according to claim 15, comprising:
`
`a reserving cavity that receives a fixed quantity of diluted plasma serving as a liquid
`
`sample;
`
`an operation cavity that is formed next to the reserving cavity in a circumferential
`
`direction, is connected to the reserving cavity via a connecting section enabling application
`
`of a capillary force, and contains a reagent for analyzing highdensity lipoprotein cholesterol;
`
`a separating cavity that is formed outside the operation cavity and is connected to the
`
`operation cavity Via a connecting passage serving as a clearance configured to apply a
`
`capillary force;
`
`a measuring passage that is adj—aeent adjacent to the separating cavity in the
`
`circumferential direction and is connected to the separating cavity via a connecting passage
`
`configured to apply a capillary force;
`
`a measuring cell formed outside the measuring passage; and
`
`a capillary area that is formed inside the measuring cell and contains an enzyme
`
`reagent and a mediator,
`
`wherein a reaction solution having reacted in the capillary area is transferred to an
`
`outer periphery of the measuring cell by increasing the centrifugal force, and then the
`
`
`
`
`
`
`
`S/N: 14/479,936
`In Reply to Office Action mailed 11/06/2015
`
`reaction solution retained on the outer periphery of the measuring cell is accessed to measure
`
`HDL of the liquid sample.
`
`18 .
`
`(Previously Presented) The analysis device according to claim 17, wherein the
`
`operation cavity comprises a reagent carrying section configured to carry the reagent for
`
`analyzing high-density lipoprotein
`
`cholesterol, the reagent carrying section protruding from the operation cavity so as to have a
`
`clearance smaller than a clearance of the operation cavity,
`
`19.
`
`(Previously Presented) The analysis device according to claim 17, further comprising
`
`an agitating rib extended in a radial direction in the operation cavity, the agitating rib being
`
`lower in height than an external wall of the operation cavity.
`
`
`
`